-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
-
Summary
-
Intellipharmaceutics International Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2015 to Q4 2018.
- Intellipharmaceutics International Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending November 30, 2018 was CA$239K, a 65.3% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (CAD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)